(Q38164425)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24256349%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

title

Cardiovascular risks associated with low-dose ibuprofen and diclofenac as used OTC (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24256349%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24256349%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Patrick Blin

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24256349%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

5

Antoine Pariente

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24256349%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

author name string

Francesco Salvo

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24256349%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Mai Duong

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24256349%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

language of work or name

English

0 references

publication date

21 November 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24256349%20AND%20SRC:MED&resulttype=core&format=json

Expert Opinion on Drug Safety

1 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24256349%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

volume

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24256349%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24256349%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

page(s)

167-179

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24256349%20AND%20SRC:MED&resulttype=core&format=json

Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group

1 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.846324

Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.846324

Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.846324

Non-steroidal anti-inflammatory drugs and risk of serious coronary heart disease: an observational cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.846324

COX-2 selective non-steroidal anti-inflammatory drugs and risk of serious coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.846324

Cardiovascular risk with non-steroidal anti-inflammatory drugs: systematic review of population-based controlled observational studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.846324

Risk of acute myocardial infarction with nonselective non-steroidal anti-inflammatory drugs: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.846324

Non-steroidal anti-inflammatory drugs and myocardial infarctions: comparative systematic review of evidence from observational studies and randomised controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.846324

Cardiovascular safety of non-steroidal anti-inflammatory drugs: network meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.846324

Cardiovascular and gastrointestinal safety of NSAIDs: a systematic review of meta-analyses of randomized clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.846324

Cardiovascular risk and inhibition of cyclooxygenase: a systematic review of the observational studies of selective and nonselective inhibitors of cyclooxygenase 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.846324

Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.846324

Non-steroidal antiinflammatory drugs and the risk of acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.846324

Cyclooxygenase-2 inhibitors and most traditional nonsteroidal anti-inflammatory drugs cause similar moderately increased risks of cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.846324

Risk of cardiovascular events and rofecoxib: cumulative meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.846324

Role of dose potency in the prediction of risk of myocardial infarction associated with nonsteroidal anti-inflammatory drugs in the general population

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.846324

Cyclooxygenase-2 inhibitors and coronary occlusion--exploring dose-response relationships

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.846324

The CADEUS study: methods and logistics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.846324

Channelling of COX-2 inhibitors to patients at higher gastrointestinal risk but not at lower cardiovascular risk: the Cox2 inhibitors and tNSAIDs description of users (CADEUS) study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.846324

NSAID use profiles derived from reimbursement data in France

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.846324

The pattern of use of non-steroidal anti-inflammatory drugs (NSAIDs) from 1997 to 2005: a nationwide study on 4.6 million people

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.846324

Risk factors for adverse events in analgesic drug users: results from the PAIN study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.846324

Diclofenac potassium 12.5mg tablets for mild to moderate pain and fever: a review of its pharmacology, clinical efficacy and safety

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.846324

The coxibs, selective inhibitors of cyclooxygenase-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.846324

The use of selective cyclooxygenase-2 inhibitors and the risk of acute myocardial infarction in Saskatchewan, Canada

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.846324

Use of first- and second-generation cyclooxygenase-2-selective nonsteroidal antiinflammatory drugs and risk of acute myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.846324

Cause-specific cardiovascular risk associated with nonsteroidal antiinflammatory drugs among healthy individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.846324

The balance between severe cardiovascular and gastrointestinal events among users of selective and non-selective non-steroidal anti-inflammatory drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.846324

Cardiovascular risks of nonsteroidal antiinflammatory drugs in patients after hospitalization for serious coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.846324

The coronary risk of cyclo-oxygenase-2 inhibitors in patients with a previous myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.846324

The risk for myocardial infarction with cyclooxygenase-2 inhibitors: a population study of elderly adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.846324

Risk of myocardial infarction and death associated with the use of nonsteroidal anti-inflammatory drugs (NSAIDs) among healthy individuals: a nationwide cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.846324

Cardiovascular safety of non-steroidal anti-inflammatory drugs among healthy individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.846324

Cardiac adverse effects associated with mitoxantrone (Novantrone) therapy in patients with MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.846324

Cardiotoxicity and other adverse events associated with mitoxantrone treatment for MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.846324

Renal failure associated with the use of celecoxib and rofecoxib

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.846324

Nonsteroidal antiinflammatory drugs and acute renal failure in elderly persons

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.846324

Resistance to loop diuretics. Why it happens and what to do about it.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.846324

Consumption of NSAIDs and the development of congestive heart failure in elderly patients: an underrecognized public health problem.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.846324

Use of non-steroidal anti-inflammatory drugs and risk of incident myocardial infarction and heart failure, and all-cause mortality in the Australian veteran community

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.846324

Increased mortality and cardiovascular morbidity associated with use of nonsteroidal anti-inflammatory drugs in chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.846324

Cyclo-oxygenase-2 inhibitors versus non-selective non-steroidal anti-inflammatory drugs and congestive heart failure outcomes in elderly patients: a population-based cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.846324

Congestive heart failure due to nonsteroidal anti-inflammatory drugs in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.846324

The influence of ibuprofen, diclofenac and sulindac on the blood pressure lowering effect of hydrochlorothiazide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.846324

Effects of captopril on peripheral hemodynamics in severe congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.846324

Effects of nabumetone, celecoxib, and ibuprofen on blood pressure control in hypertensive patients on angiotensin converting enzyme inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.846324

Defining the problem of treating the patient with hypertension and arthritis pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.846324

Interactions of NSAIDs with diuretics and beta-blockers mechanisms and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.846324

Factors associated with blood pressure changes in patients receiving diclofenac or etoricoxib: results from the MEDAL study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.846324

Acute and chronic effects of nonsteroidal antiinflammatory drugs on glomerular filtration rate in elderly patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.846324

The impact of ibuprofen on the efficacy of antihypertensive treatment with hydrochlorothiazide in elderly persons

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.846324

Meta-analysis of cyclooxygenase-2 inhibitors and their effects on blood pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.846324

Do COX-2 inhibitors raise blood pressure more than nonselective NSAIDs and placebo? An updated meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.846324

Comparison of cyclooxygenase-1 and -2 inhibitory activities of various nonsteroidal anti-inflammatory drugs using human platelets and synovial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.846324

Clinical pharmacology of platelet, monocyte, and vascular cyclooxygenase inhibition by naproxen and low-dose aspirin in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.846324

Effects of Cyclooxygenases Inhibitors on Vasoactive Prostanoids and Thrombin Generation at the Site of Microvascular Injury in Healthy Men

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.846324

Cyclooxygenase inhibitors and the antiplatelet effects of aspirin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.846324

Nonselective nonsteroidal antiinflammatory drugs and cardiovascular risk: are they safe?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.846324

Lower risk of thromboembolic cardiovascular events with naproxen among patients with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.846324

Association between naproxen use and protection against acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.846324

Long-term use of non-steroidal anti-inflammatory drugs and the risk of myocardial infarction in the general population

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.846324

Variability in risk of gastrointestinal complications with individual non-steroidal anti-inflammatory drugs: results of a collaborative meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.846324

Cardiovascular safety and gastrointestinal tolerability of etoricoxib vs diclofenac in a randomized controlled clinical trial (The MEDAL study).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.846324

Non-narcotic analgesic dose and risk of incident hypertension in US women

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.846324

Stroke risk and NSAIDs: a systematic review of observational studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.846324

Cardiovascular outcomes in new users of coxibs and nonsteroidal antiinflammatory drugs: high-risk subgroups and time course of risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.846324

Nonaspirin NSAIDs, cyclooxygenase 2 inhibitors, and the risk for stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.846324

Ex vivo assay to determine the cyclooxygenase selectivity of non-steroidal anti-inflammatory drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.846324

Cyclooxygenase-1 and cyclooxygenase-2 selectivity of non-steroidal anti-inflammatory drugs: investigation using human peripheral monocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.846324

Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: a full in vitro analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.846324

Systematic review of trials of the effect of continued use of oral non-selective NSAIDs on blood pressure and hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.846324

Harmful effects of NSAIDs among patients with hypertension and coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.846324

Duration of treatment with nonsteroidal anti-inflammatory drugs and impact on risk of death and recurrent myocardial infarction in patients with prior myocardial infarction: a nationwide cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.846324

Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.846324

Economic analysis of celecoxib versus diclofenac plus omeprazole for the treatment of arthritis in patients at risk of ulcer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.846324

Applying propensity scores estimated in a full cohort to adjust for confounding in subgroup analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.846324

Using high-dimensional propensity scores to automate confounding control in a distributed medical product safety surveillance system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.846324

High-dimensional propensity score adjustment in studies of treatment effects using health care claims data

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.846324

A case-control study of acetaminophen use in relation to the risk of first myocardial infarction in men

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.846324

Concomitant use of ibuprofen and paracetamol and the risk of major clinical safety outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.846324

Risks and benefits of COX-2 inhibitors vs non-selective NSAIDs: does their cardiovascular risk exceed their gastrointestinal benefit? A retrospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.846324

Nonsteroidal antiinflammatory drugs, acetaminophen, and the risk of cardiovascular events

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.846324

Acetaminophen increases blood pressure in patients with coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.846324

Blood pressure destabilization on nonsteroidal antiinflammatory agents: acetaminophen exposed?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.846324

Risk of Death or Reinfarction Associated With the Use of Selective Cyclooxygenase-2 Inhibitors and Nonselective Nonsteroidal Antiinflammatory Drugs After Acute Myocardial Infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.846324

Cyclooxygenase-1 and Cyclooxygenase-2 Selectivity of Widely Used Nonsteroidal Anti-Inflammatory Drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.846324